D. E. Shaw & Co., Inc. Cerus Corp Transaction History
D. E. Shaw & Co., Inc.
- $100 Billion
- Q1 2025
A detailed history of D. E. Shaw & Co., Inc. transactions in Cerus Corp stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 3,790,731 shares of CERS stock, worth $5.23 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,790,731
Previous 3,428,933
10.55%
Holding current value
$5.23 Million
Previous $5.28 Million
0.21%
% of portfolio
0.01%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding CERS
# of Institutions
167Shares Held
149MCall Options Held
24.2KPut Options Held
44.4K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl20.7MShares$28.5 Million0.31% of portfolio
-
Baker Bros. Advisors LP New York, NY19.4MShares$26.7 Million0.32% of portfolio
-
Black Rock Inc. New York, NY13.9MShares$19.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$14.6 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT8.32MShares$11.5 Million0.07% of portfolio
About CERUS CORP
- Ticker CERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 177,090,000
- Market Cap $244M
- Description
- Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...